CRIS Current Research Information System

MURATORI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.697
EU - Europa 4.433
AS - Asia 2.626
AF - Africa 261
OC - Oceania 18
SA - Sud America 17
Totale 14.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.669
GB - Regno Unito 1.240
CN - Cina 940
IT - Italia 746
VN - Vietnam 707
SG - Singapore 618
SE - Svezia 609
DE - Germania 604
UA - Ucraina 262
RU - Federazione Russa 258
IN - India 257
IE - Irlanda 172
FR - Francia 160
EE - Estonia 86
ZA - Sudafrica 85
TG - Togo 72
CH - Svizzera 69
CI - Costa d'Avorio 61
FI - Finlandia 54
BG - Bulgaria 42
JO - Giordania 31
NL - Olanda 31
CA - Canada 23
NG - Nigeria 21
AT - Austria 18
SC - Seychelles 18
BE - Belgio 17
ID - Indonesia 15
GR - Grecia 14
RO - Romania 12
AU - Australia 11
HR - Croazia 11
JP - Giappone 8
TR - Turchia 8
HK - Hong Kong 7
NZ - Nuova Zelanda 7
IR - Iran 6
PL - Polonia 6
PT - Portogallo 6
BR - Brasile 5
CL - Cile 5
ES - Italia 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
MX - Messico 4
AR - Argentina 3
MY - Malesia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
BD - Bangladesh 2
EG - Egitto 2
FK - Isole Falkland (Malvinas) 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
LU - Lussemburgo 2
TH - Thailandia 2
AM - Armenia 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
MA - Marocco 1
NO - Norvegia 1
PA - Panama 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 14.052
Salva come PNG Salva come JPEG
Città #
Southend 1.105
Fairfield 927
Dong Ket 564
Chandler 552
Singapore 528
Ashburn 526
Seattle 436
Woodbridge 436
Houston 409
Wilmington 376
Santa Clara 375
Cambridge 325
Princeton 258
Ann Arbor 219
Dublin 171
Jacksonville 167
Boardman 156
Nanjing 128
Bologna 116
Padova 107
Westminster 105
Berlin 99
Jinan 82
Lomé 72
Abidjan 61
Bern 56
Saint Petersburg 55
Shenyang 54
Beijing 52
Milan 50
San Diego 48
Helsinki 47
Changsha 40
Sofia 40
Hebei 39
Bremen 36
Mülheim 36
Des Moines 34
Nanchang 32
Amman 31
Guangzhou 30
Rome 29
Turin 29
New York 28
Tianjin 23
Phoenix 22
Haikou 21
Medford 21
Zhengzhou 21
Abeokuta 20
Dearborn 20
Frankfurt am Main 20
Hangzhou 20
Los Angeles 20
Taiyuan 20
Bühl 18
Mahé 18
Ningbo 18
Norwalk 18
Shanghai 18
Brussels 17
Jiaxing 17
Falls Church 16
Taizhou 16
Verona 16
Yubileyny 16
London 14
Vienna 14
Jakarta 13
Olalla 13
Fuzhou 12
Redwood City 12
Fremont 11
San Francisco 11
Todi 11
Toronto 11
Washington 11
Wuhan 11
Florence 10
Moscow 10
Bolzano 9
Nuremberg 9
Falkenstein 8
Mumbai 8
Parma 8
Redmond 8
Tokyo 8
Chengdu 7
Leawood 7
Amsterdam 6
Andover 6
Brescia 6
Buffalo 6
Chongqing 6
Fort Worth 6
Kunming 6
Lanzhou 6
Lappeenranta 6
Modena 6
Mountain View 6
Totale 9.784
Salva come PNG Salva come JPEG
Nome #
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 222
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 214
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 193
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 192
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 181
Clinical and serological profile of primary biliary cirrhosis in men. 179
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 178
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 173
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 172
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 172
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 171
Anti-actin IgA antibodies in severe coeliac disease 167
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 163
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 161
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 158
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 155
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 152
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 151
Antinuclear antibodies in COVID 19 151
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 149
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 148
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 144
Autoantibodies in Autoimmune Hepatitis 144
Autoimmune liver disease 2007. 140
Diagnosis and therapy of autoimmune hepatitis. 140
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 139
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 138
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 136
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 135
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 134
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 134
Antitransglutaminase antibodies and giardiasis 132
Autoimmune hepatitis in Italy: the Bologna experience. 132
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 132
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 131
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 130
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 130
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 129
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 129
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 129
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 128
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 128
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study 126
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 125
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 125
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 123
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 123
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 120
Autoimmune liver disease serology in acute hepatitis E virus infection 120
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 117
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 117
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 117
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 113
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 112
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 111
Diagnostic approach to autoimmune hepatitis 111
HCV and autoimmunity. 110
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 109
Celiac disease in autoimmune cholestatic liver disorders 109
Nuclear Envelope Protein Autoantibodies/Antilamin Autoantibodies (Chapter 26) 109
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 107
Standardization of Autoantibody Testing in Autoimmune Hepatitis 107
Regulatory T cell defects in adult autoimmune hepatitis. 106
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 105
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 105
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 105
Specific antinuclear reactivities in primary biliary cirrhosis 104
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 104
Two of them do it better: Novel serum biomarkers improve autoimmune hepatitis diagnosis 104
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 103
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 103
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 102
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 102
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 100
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 100
Serum Smooth Muscle Antibodies (SMA). 98
Diagnosis of primary biliary cholangitis in a "teen" male patient 98
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 98
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 97
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. 94
null 92
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 92
Hepatitis C and autoreactivity. 91
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 90
Review article: autoimmune hepatitis - current management and challenges 89
Sex differences associated with primary biliary cirrhosis. 88
Primary Biliary Cholangitis: advances in management and treatment of the disease. 88
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 88
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 87
Non organ specific autoantibodies in children with chronic hepatitis C virus infection 87
Current topics in autoimmune hepatitis. 87
The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies 85
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 85
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 84
HCV E1E2-MF59vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial 83
Genetic distinction between autoimmune hepatitis in Italy and North America 83
Susceptibility to thyroid disorders in hepatitis C 82
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 82
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. 79
null 79
Totale 12.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.596 0 0 0 0 0 0 0 451 483 282 160 220
2020/20212.125 342 130 71 67 50 84 44 169 132 124 90 822
2021/20222.463 189 59 175 208 204 119 76 161 102 163 581 426
2022/20232.403 333 331 127 309 130 175 96 127 376 95 184 120
2023/2024736 48 111 51 68 53 115 39 66 21 43 62 59
2024/20252.124 171 449 323 250 545 170 184 32 0 0 0 0
Totale 14.334